PT741570E - Metodo para a prevencao ou reducao de reaccoes de fotossensibilidade e/ou fototoxicidade a medicacoes - Google Patents

Metodo para a prevencao ou reducao de reaccoes de fotossensibilidade e/ou fototoxicidade a medicacoes

Info

Publication number
PT741570E
PT741570E PT95907337T PT95907337T PT741570E PT 741570 E PT741570 E PT 741570E PT 95907337 T PT95907337 T PT 95907337T PT 95907337 T PT95907337 T PT 95907337T PT 741570 E PT741570 E PT 741570E
Authority
PT
Portugal
Prior art keywords
phototoxicity
photosensibility
medications
reactions
prevention
Prior art date
Application number
PT95907337T
Other languages
English (en)
Inventor
Paul Dale Klimstra
Barbara Roniker
Edward Allen Swabb
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of PT741570E publication Critical patent/PT741570E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Photometry And Measurement Of Optical Pulse Characteristics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT95907337T 1994-01-28 1995-01-12 Metodo para a prevencao ou reducao de reaccoes de fotossensibilidade e/ou fototoxicidade a medicacoes PT741570E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/188,296 US5668134A (en) 1994-01-28 1994-01-28 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications

Publications (1)

Publication Number Publication Date
PT741570E true PT741570E (pt) 2003-09-30

Family

ID=22692575

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95907337T PT741570E (pt) 1994-01-28 1995-01-12 Metodo para a prevencao ou reducao de reaccoes de fotossensibilidade e/ou fototoxicidade a medicacoes

Country Status (9)

Country Link
US (2) US5668134A (pt)
EP (2) EP1384479A1 (pt)
AT (1) ATE239478T1 (pt)
AU (1) AU1560595A (pt)
DE (1) DE69530673T2 (pt)
DK (1) DK0741570T3 (pt)
ES (1) ES2199238T3 (pt)
PT (1) PT741570E (pt)
WO (1) WO1995020387A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040037895A1 (en) * 2002-08-23 2004-02-26 Alex Zhu Methods of treating involuntary facial spasms and facial wrinkles
US7435237B2 (en) 2003-06-02 2008-10-14 Boston Scientific Scimed, Inc. Mixing syringes with breakable septums
EP1488787A1 (en) * 2003-06-20 2004-12-22 Berlin-Chemie Ag Topical stabilized formulations containing ketoprofen
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
RU2612810C2 (ru) * 2015-02-26 2017-03-13 Игорь Михайлович Корниловский Способ применения нестероидных противовоспалительных средств в эксимерлазерной хирургии роговицы
US20220142208A1 (en) * 2020-11-12 2022-05-12 Bossa Nova Superfruit Company Sparkling water micronutrient delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US429556A (en) * 1890-06-03 Truss
EP0107150B2 (de) * 1982-10-18 1992-04-15 Siemens Aktiengesellschaft Vorrichtung zur Abgabe von Medikamenten
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
GB8719932D0 (en) * 1987-08-24 1987-09-30 Professional Packaging Ltd Medication timing device
US5142484A (en) * 1988-05-12 1992-08-25 Health Tech Services Corporation An interactive patient assistance device for storing and dispensing prescribed medication and physical device
US5170380A (en) * 1990-12-14 1992-12-08 Wheaton Holding, Inc. Medication container holding device indicating usage time
US5313439A (en) * 1992-07-17 1994-05-17 Dan Albeck Timer device for medications
US5331919A (en) * 1992-08-03 1994-07-26 John Root Medication scheduling device

Also Published As

Publication number Publication date
US5668134A (en) 1997-09-16
WO1995020387A1 (en) 1995-08-03
EP1384479A1 (en) 2004-01-28
DE69530673D1 (de) 2003-06-12
EP0741570B1 (en) 2003-05-07
DK0741570T3 (da) 2003-09-01
EP0741570A1 (en) 1996-11-13
DE69530673T2 (de) 2004-04-08
ES2199238T3 (es) 2004-02-16
ATE239478T1 (de) 2003-05-15
US6172069B1 (en) 2001-01-09
AU1560595A (en) 1995-08-15

Similar Documents

Publication Publication Date Title
ATE152910T1 (de) Verwendung von taxol zur herstellung eines arzneimittels zur behandlung von krebs
BR9608405A (pt) Composto composi-Æo farmaceutica e processo para tratar um paciente que sofre de um distÚrbio fisiolÄgico
ATE192142T1 (de) Aminosäurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT741570E (pt) Metodo para a prevencao ou reducao de reaccoes de fotossensibilidade e/ou fototoxicidade a medicacoes
EP0404283A3 (de) 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
OA09190A (fr) "Procédés de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïques et de médicaments les contenant".
AU7077096A (en) Selective beta 3 adrenergic agonists
DE69426865D1 (de) Pharmazeutische Zusammensetzungen enthaltend Pyryliumverbindungen, Pyryliumsalze und Verfahren zur Herstellung eines Medikaments enthaltend diese Verbindungen
FR2707085B1 (fr) Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
ZA93275B (en) Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them.
ATE133949T1 (de) 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
FR2693196B1 (fr) Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.
FR2702375B1 (fr) Microcapsules à libération progressive, leur procédé de préparation et compositions pharmaceutiques ou vétérinaires les contenant.
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
ATE155136T1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2058813T3 (es) Un metodo para la fabricacion de un medicamento para el tratamiento de la conmocion.